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The poxvirus molluscum contagiosum (MC) has a worldwide distribution and its prevalence is on the rise. Here we report
that the MCV MC013L protein inhibits glucocorticoid and vitamin D, but not retinoid or estrogen, nuclear receptor
transactivation. A direct interaction of MC013L with glucocorticoid and vitamin D receptor is supported by yeast two-hybrid,
GST pull-down, and far Western blot analyses. Glucocorticoids act as potent inhibitors of keratinocyte proliferation, while
vitamin D and retinoids promote and block terminal differentiation, respectively. Therefore, MC013L may promote efficient
virus replication by blocking the differentiation of infected keratinocytes. MC013L may be the first member of a new class
of poxvirus proteins that directly modulate nuclear receptor-mediated transcription. © 2000 Academic Press
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tIntroduction. With the extinction of variola virus, pox-
virus molluscun contagiosum (MCV) is the only poxvirus
circulating in the human population. Molluscum conta-
giosum presents as small clusters of epidermal, flesh-
colored, raised nodules of 2–5 mm in diameter in immu-
nocompetent individuals (1). The lesions are generally
painless, appearing on the trunk and limbs (except
palms and soles). The disease can be fairly common in
children and sexually transmitted in teenagers and
adults. Lesions can persist for as little as 2 weeks or as
long as 2 years and spontaneously resolve. Reinfections
can be common, suggesting that the virus, or its site of
replication, does not induce an effective immune re-
sponse. MCV is an opportunistic infection of immuno-
compromised individuals and is considered a cutaneous
marker of severe immunodeficiency in HIV-infected pa-
tients, especially those with severely depressed CD41 T
cell numbers. The prevalence of MCV in human popula-
tions is on the rise.
The inability to replicate MCV in cell culture has ham-
pered its molecular biological characterization until now.
DNA sequence analysis of the MCV type 1 genome (190
kb) has revealed promoters, transcription termination
signals, and DNA concatemer resolution sequences
which are highly homologous to those of orthopoxvi-
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17ruses (OPV) such as vaccinia virus (VV) (2, 3). Further
analysis of the entire protein coding sequence has al-
lowed the identification of 182 open reading frames
(ORFs). One hundred five ORFs have direct counterparts
in OPV and are located mainly in the central portion of
the genome, encoding functions essential for the pro-
duction of progeny virions. The remaining 77 ORFs are
without OPV counterparts and are mainly located in the
terminal regions of the MCV genome, which by analogy
to the OPV should contain the hrm (host response mod-
ifier) genes. These genes target the multifactorial re-
sponses to infection, host cell macromolecular synthetic
processes, and apoptotic mechanisms. Because MCV
replicates only in human keratinocytes of the epidermis,
it is probable that the putative MCV hrm genes will have
evolved to modulate the skin immune system and kera-
tinocyte homeostasis. Gene products have been shown
to inhibit chemokine action (MC148R) (4, 5) and apopto-
sis (MC159L and MC160L) (6, 7) and to scavenger reac-
tive oxygen metabolites (MC066L) (8). Recently, ORFs
MC051L, MC053L, and MC054L were shown to have
homology with a family of IL-18 binding proteins (9, 10),
and the latter two were also shown to bind IL-18 (11). In
his report we have investigated the function of the pu-
ative hrm MC013L.
Results. Similarity searches of the nonredundant pro-
ein database and the expressed sequence tag databaseith MC013L nucleotide sequences revealed significant
omology only to the DnaJ family of molecular chaper-
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18 RAPID COMMUNICATIONones (Fig. 1) (2, 3). Members of this family regulate
protein folding, assembly, and transport in both eukary-
otic and prokaryotic systems (12, 13). There are two
egions of significant homology to the DnaJ protein fam-
ly. First, MC013L residues 1 to 64 show homology with
-domains, which contain the canonical HPD motif that
efines the DnaJ family. This MCV J-domain, however,
ould not substitute functionally for the J-domain of the
scherichia coli DnaJ protein in chimeric proteins in vivo
data not shown). The second homologous region (resi-
ues 116 to 157) of MC013L corresponds to an area of
naJ proteins of unknown function. In DnaJ, this region
alls between glycine/phenylalanine-rich and cysteine-
FIG. 1. Homology of MC013L with four members of the DnaJ family of p
HPD J-domain motif and a LXXLL motif that can mediate binding of traFIG. 2. Nuclear localization of MC013L. COS-7 cells transiently expressing
rabbit anti-MC013L followed by goat anti-rabbit conjugated to FITC to determrich regions, which are highly conserved among DnaJ
family members but are not present in the MC013L pro-
tein. Within this second region, MC013L displays a
LXXLL motif, which has been shown to be necessary and
sufficient for mediating binding of some transcriptional
coactivators such as RIP-140, SRC-1, and CBP to various
liganded nuclear receptors (14). There does not appear
to be any other significant homology between MC013L
and these transcriptional coactivators. The possibility of
a role for MC013L in modulating host cell transcriptional
machinery gained additional weight with the observed
localization of MC013L to the nucleus following transient
expression in COS-7 cells (Fig. 2).
. Amino acids with identity are boxed. Bars locate the highly conserved
tional coactivators to nuclear receptors.MC013L were stained with (A) DAPI to stain DNA and (B) polyclonal
ine the distribution of MC013L.
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19RAPID COMMUNICATIONMC013L Selectively Inhibits Nuclear Receptor-Medi-
ated Transcription without an Absolute Requirement for
an Intact LETLL Sequence. Vitamin D is a potent pro-
moter of keratinocyte differentiation (15). The biologically
active metabolite of vitamin D is 1,25-dihydroxyvitamin D3
[1,25-(OH)2D3], and its cellular actions are mediated
through the vitamin D nuclear receptor (VDR). We tested
the MC013L protein in a COS-7 transient expression
system for its ability to modulate vitamin D-mediated
transactivation (Fig. 3A). Expression of MC013L resulted
in the dose-dependent inhibition of 1,25-(OH)2D3/VDR-
ependent transactivation of a growth hormone (GH)
eporter construct by more than 70% compared to similar
ransfections with an expression vector carrying MC013L
n an antisense orientation (Fig. 3A). Western blot anal-
sis verified that the MC013L inhibitory effect was not
ediated through reduced synthesis of VDR. In an effort
o define the specificity of MC013L inhibition, other mem-
ers of the nuclear receptor superfamily were cotrans-
ected into COS-7 cells with pMT3A-MC013L (Fig. 3B).
nhibition was observed against ligand-mediated glu-
ocorticoid receptor (GR)-dependent, but not retinoid
cid receptor (RAR)-dependent, transactivation. In this
xperiment, MC013L showed a modest inhibition of es-
rogen receptor (ER)-dependent transactivation with a
.5-fold increase in GH synthesis in the presence of
igand and MC013L versus a 13-fold increase in a control
eaction. In two other experiments, however, MC013L
nhibition of ER-dependent transactivation was not sta-
istically significant [27- and 30-fold (Experiment 2) and
1- and 16-fold (Experiment 3) increases in GH synthesis
n the presence and absence of MC013L, respectively].
FIG. 3. MC013L affects nuclear receptor function. (A) MC013L-me
transactivation. COS-7 cells were transfected with pSG5–VDR, report
MT3A DNA in the presence or absence of 1,25-(OH)2D3. The amount
Cell lysates were analyzed by Western blot for synthesis of MC013L an
member of the nuclear receptor family. COS-7 cells were transfected w
and an appropriate reporter construct with or without ligand. GH secre
shown. (C) MC013L selectively inhibits nuclear receptor-mediated tra
MC013L mutations at L122A, L125A, L126A, and L125/126A were assaye
proteins were synthesized and transported to the nucleus as efficiently
in the presence of ligand; P , 0.05. A representative of two experimurthermore, expression of MC013L did not significantly
lter the expression of general promoter constructs,uch as TK–GH and RSV–GH, under similar transfection
onditions (data not shown). Taken together, these stud-
es are consistent with the MC013L protein exerting a
elective inhibitory effect on VDR- and GR-mediated tran-
cription. To determine if the MC013L LETLL sequence
as important in the inhibition of VDR/GR transactiva-
ion, we used in vitro mutagenesis methods to create
ite-specific mutations in this region. The LETLL se-
uence was mutated by the substitution of alanine for
eucine residues (Fig. 3C). The L122A, L126A, and L125/
26A mutations resulted in a diminution of the inhibition
f both VDR- and GR-dependent transactivation by
C013L; however, the L125A mutation had no effect. This
esult was in contrast to the absolute requirement for the
XXLL motif in the interaction of RIP-140, SCR-1, and CBP
ith tested liganded nuclear receptors (14).
MC013L Directly Interacts with VDR and GR Nuclear
eceptors. Direct MC013L interactions with VDR and GR
ere examined in vivo using yeast two-hybrid systems
nd in vitro with glutathione S-transferase (GST) pull-
own and far Western blot assays. The MC013L gene
as expressed as a fusion protein with the activation
omain of Gal4 and tested for interaction with the ligand-
inding domains of VDR, GR, ER, and RAR, which were
used to the DNA-binding domain of Gal4. Interaction (as
ndicated by growth on histidine-deficient plates) was
bserved between MC013L and VDR, but not with RAR,
R, or ER (data not shown). As expected, the MC013L
usion protein did not interact with bait constructs of
nrelated proteins p53, snf4, and Ga. A more sensitive
and quantitative measurement of interaction in this sys-
concentration-dependent inhibition of vitamin D receptor-mediated
struct VDRE4–TATA–GH, and increasing ratios of pMT3A–MC013L to
th hormone (GH) secreted in 24 h was determined by immunoassay.
roteins. (B) MC013L affects the transcriptional activity of an additional
smids expressing GR, ER, or RAR cDNAs, pMT3A–MC013L or pMT3A,
24 h was assayed as before. A representative of three experiments is
ion without an absolute requirement for an intact LETLL sequence.
VDR and GR transient gene expression systems. The mutant MC013L
MC013L (data not shown). * Significantly different from the WT value
shown.diated,
er con
of grow
d VDR p
ith pla
tion in
nscript
d in thetem is the liquid b-galactosidase assay, which clearly
demonstrated a strong MC013L interaction with the li-
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20 RAPID COMMUNICATIONgand-binding domain of VDR in the presence and ab-
sence of ligand (Fig. 4A). The presence of ligand in-
creased the interaction of MC013L with VDR 1.6-fold
compared to a 3.2-fold increase noted for VDR interac-
tion with its heterodimeric partner, RXR (Experiment 2).
Interestingly, none of the LETLL mutations prevented
FIG. 4. Direct interaction of MC013L with the ligand-binding domain
eceptors in the yeast two-hybrid system in the presence and absence
iquid culture and analyzed in triplicate for b-galactosidase activity in
eoxycorticosterone; ER, b-estradiol, and RAR, all-trans-retinoic acid).
xperiments is shown. (B) In vitro interaction between VDR, GR, and E
f ligand. 10% of the input for each MC013L protein is shown. 2, GST al
C) From (B) the WT and LXXLL mutant MC013L 35S-labeled proteins bi
f input counts. (D) Direct interaction of MC013L with nuclear receptors
ubjected to SDS–PAGE and analyzed by the far Western blot assay usin
f three experiments is shown.MC013L interaction with VDR. In fact, the L126A and
L125/126A mutations appeared to enhance the interac-tion, even though they were associated with a modest
inhibition of MC013L function in the VDR/GR transactiva-
tion assay. Again, no interaction could be demonstrated
between MC013L and GR, ER, or RAR, yet these receptor
fusions all interacted with the positive control GRIP. Be-
cause MC013L failed to inhibit ER or RAR transactivation,
R and GR. (A) Quantitation of the interaction of MC013L with nuclear
nd. Yeast cells containing bait and prey vectors were inoculated into
sence or absence of the appropriate ligand (VDR, 1,25-(OH)2D3; GR,
n among replicates was ,30% of the mean. A representative of four
35S-labeled MC013L WT and indicated LETLL mutants in the absence
VDR; G, GR, and E, ER. A representative of three experiments is shown.
GST or GST–nuclear receptor fusions are expressed as percentages
bsence of ligand. One microgram of GST–VDR, GR, or ER fusions was
beled WT or L125/126A mutant GST–MC013L probes. A representatives of VD
of liga
the pre
Variatio
R with
one; V,
nding to
in the a
32we had not expected to see interaction in the yeast
two-hybrid assay; however, with GR this was not the
21RAPID COMMUNICATIONcase. We also attempted to demonstrate GR interaction
with MC013L in the more sensitive LexA yeast two-hybrid
system and through reversal of the fusion partners (data
not shown). Still no interaction could be demonstrated.
Since the failure to demonstrate an interaction of GR with
MC013L may be a property of this assay system, we
tested for interaction in the GST pull-down and the far
Western blot assays. In the GST pull-down assay, radio-
labeled MC013L WT protein interacted with VDR and GR,
but not with GST alone or GST–ER in the absence of
ligand (Figs. 4B and 4C). GST–ER was functional as it
interacted with NCoA-62 (data not shown) (16). The in-
teraction of GR with MC013L appeared to be ;4-fold
weaker than that with VDR. VDR interacted with L122A
and L126A mutants as efficiently as with WT MC013L, but
less so than with L125A and L125/126A mutants. GR had
a similar relative range of interactions with the LETLL
mutants, except for the L125A mutant, with which there
was only a background level of interaction. All interac-
tions were increased in the presence of the appropriate
ligand (data not shown). Far Western blot analyses dem-
onstrated a direct interaction of WT and L125/126A
MC013L with VDR and GR, but not with ER (Fig. 4D).
Taken together the above findings are consistent with a
ligand independent, direct interaction between MC013L
and VDR or GR that does not require an intact LETLL
sequence.
Expression of MC013L during MCV Natural Replication
Cycle. Histopathological observations and in situ [3H]thy-
midine labeling of lesions suggest that MCV replicates
during the 9 to 15 days it takes the infected keratinocyte
to reach the stratum granulosum, with virus specific
changes detectable initially in the lower layers of the
stratum spinosum (several cells distal to the basement
membrane) (17–20). To identify the virus-infected cells
expressing MC013L, molluscum contagiosum lesions
were analyzed by immunocytochemistry. The light-level
photograph displayed in Fig. 5 reveals the presence of
MC013L protein in patches of keratinocytes in the lower
layers of the stratum spinosum proximal to the basal
layer. The loss of MC013L staining from the keratinocyte
as it migrates through the epidermis may be explained
by degradation of the protein or by masking by cellular or
viral proteins.
Discussion. Taken together, these findings indicate
that the MC013L protein inhibits VDR and GR transacti-
vation of a reporter gene construct and that the inhibition
is most likely mediated through direct interaction with
the nuclear receptor. The presence of an LXXLL motif
and a DnaJ domain in the MC013L protein suggested
possible mechanisms of interaction with VDR and GR,
which were tested. For example, the DnaJ domain of
MC013L could interfere with the conversion of GR from a
non-steroid-binding to a steroid-binding form by compet-
ing with hsp40 (DnaJ homolog) in assembly of the hsp90,the hsp70, and the GR ternary complex (21, 22). Since
J-domain interactions with hsp70 have been shown to be
dependent on the HPD motif (13, 23), we tested this
possibility by introducing H30Q or D32N mutations into
MC013L and by testing the mutants in the GR transacti-
vation assay. The MC013L HPD mutants were as active
as the WT protein in this assay (data not shown). Another
possible mechanism of action could involve the binding
of MC013L to the nuclear receptor’s AF-2 domain through
its LXXLL motif, thereby blocking access of the cotrans-
criptional activators. This simple competition model was
ruled out by the analysis of a series of mutations in the
LETLL sequence of MC013L. Except for the L125A mu-
tation, mutations in the LETLL sequence did not prevent
MC013L’s interaction with VDR or GR as measured in
yeast two-hybrid, GST pull-down, and far Western blot
assays. Furthermore, inhibition by MC013L of VDR or GR
transactivation assays in COS-7 cells was reversed only
modestly by the LETLL mutations, except for the L125A
mutant, which had no effect. In comparison, these same
mutations in LXXLL motifs totally abolished the interac-
tion of cotranscriptional activators RIP-140, SRC-1, and
CBP with ER and RAR (14). Also, if MC013L’s inhibition of
VDR and GR were mediated through the LXXLL motif, we
would have expected ER and RAR transactivations to be
similarly inhibited by MC013L, but they were not. Finally,
MC013L interacts with VDR and GR in the absence of
ligand, whereas the LXXLL-mediated interaction of co-
transcriptional activators and nuclear receptors is ligand
dependent. Taken together, these observations argue
that MC013L inhibition of VDR and GR transactivation is
not mediated through the regulatory mechanisms depen-
dent on intact HPD or LXXLL motifs.
Keratinocyte homeostasis is dependent to a large ex-
tent on the fine-tuned interaction of epidermal growth
factor and keratinocyte growth factor and on a number of
hormones (estrogen, glucocorticoids, retinoids, and vita-
min D) in the presence of calcium, which ultimately
regulates the balance between cell proliferation, cell
differentiation, and apoptosis. MC013L may help to opti-
mize virus replication by maintaining keratinocytes in a
proliferating state through blocking of the positive sig-
nals for differentiation induced by transactivation of nu-
clear receptors such as VDR and GR, but leaving unaf-
fected retinoid-stimulated gene expression (Fig. 6). Reti-
noids block terminal differentiation of keratinocytes and
antagonize the prodifferentiation actions of 1,25(OH)2D3
(15). This possible role of MC013L would require the
keratinocyte to be infected prior to irreversible progres-
sion into the differentiation pathway and would make the
keratinocyte stem and transit amplifying cells the likely
targets of a productive MCV infection. The stem cells
divide infrequently but have the ability to regenerate the
epidermis, whereas the transit amplifying cells are de-
rived from stem cells and have a limited self-renewal
capacity of about three rounds of division (24). Both stem
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22 RAPID COMMUNICATIONcells and transit amplifying cells are found in the epide-
mis as patches of b1-integrin bright and dull cells, re-
pectively. A similar patched distribution of MC013L-
ositive cells was observed in sections from molluscum
esions and may indicate that either MCV-infected stem
FIG. 5. MC013L protein in the life cycle of molluscum contagiosu
eratinocytes in or proximal to the basal layer of the epidermis are in
igrate toward the surface of the epidermis over a period of 9–15 d
ssembles progeny virions, which ultimately fill greatly enlarged keratin
athognomonic for the disease (1, 33). The basal layer of the epiderm
(brown) are indicated by arrows. The top left corner depicts the centr
staining pattern was observed with sections from two other MCV lesion
tissue sections (data not shown).
FIG. 6. Proposed model for MC013L modulation of keratinocyte proells or transit amplifying cells express MC013L, but not
oth. This issue is currently under investigation.
b
mThe study of MCV functions that modulate host pro-
esses should provide insights into the biology of the
eratinocyte. In this study, we have shown that MC013L
electively inhibits transactivation by VDR and GR. To our
nowledge, this is the first study describing the direct,
s. Detection of MC013L in human lesions by immunocytochemistry.
with MCV through minor abrasions in the skin. As the infected cells
CV sequentially expresses its genes, replicates genomic DNA, and
. These virus-filled structures are known as molluscum bodies and are
ndicated with arrowheads. Patches of MC013L antigen-positive cells
of the lesion, which opens to the surface of the epidermis. A similar
not shown). Preimmune rabbit sera were nonreactive with consecutive
n and differentiation.m viru
fected
ays, M
ocytes
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s (dataut selective, interaction of a virus-encoded protein with
embers of the nuclear receptor family and inhibition of
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23RAPID COMMUNICATIONtheir transactivation. Perhaps MC013L modulates a novel
nuclear receptor regulatory pathway important in the
regulation of keratinocyte proliferation and differentia-
tion. If so, the MC013L protein may have a host homolog,
as do a number of viral proteins that appear to have been
“pirated” from the host and modulate inflammatory, im-
mune, and apoptotic processes (25).
Materials and Methods. Multiple alignments. The mul-
tiple alignments were manually created and edited with
SeqVu (Garvan Institute for Medical Research, Sydney,
NSW, Australia). Swiss Protein Accession Nos. MCV,
P31689; coxiella burnetii, P42381; Human, P31689; E. coli,
08622, and streptomyces coelicolor, P40170. Selected
aps were introduced into the MC013L sequence to
aximize matches.
Expression Plasmids and Reporter Constructs. The
C013L open reading frame was amplified by PCR from
CV genomic DNA using specific primers containing
estriction endonuclease recognition sites (59 primer:
9-GCGGAATTCGACCATGGATCCGCATGAAGTTCTC-39;
9 primer: 59-GCGGAATTCAAG CTTATAGCTTTGGCAGT-
GACTC-39). The resulting product was purified and
loned into EcoRI-digested pMT3A, which contains the
V40 origin and expresses the cloned gene from the
denovirus major late promoter (26). MC013L mutants
ere constructed using pMT3A–MC013L DNA, muta-
enic oligonucleotides (L122A, 59-GCCGCGGACAC-
ACGCCGAGACGCTCTTGG-39; L125A,59-GACCTC-
AGACGGCCTTGGATCTGTCGTCGCTCG-39; L126A, 59-
ACCTCGAGACGCTCGCGGATCTGTCGCTCG-39; and
125/126A, 59-GACCTCGAGACGGCCGCGGATCTGTC-
CTCG-39), and the GeneEditor site-directed mutagene-
is system (Promega Corporation, WI).
Functional Assays. COS-7 cells were transfected by
he calcium phosphate (Figs. 3a and 3b) or liposome
Fugene 6; Roche Molecular Biochemicals, Indianapolis,
N) (Fig. 2c) methods with 10–20 ng of pSG5–VDR1–427
(27), 2–2.5 mg of VDRE4–TATA–GH (28), and increasing
amounts of pMT3A–MC013L, made up to 1 mg with
empty vector. Other nuclear receptor/reporter plasmid
pairs (pSG5–GR1–783/GRE
2–TK–GH; pSG–ER1–595/ERE
2–
ATA–GH, and pSG–RAR1–391/RARE
4–TATA–GH) (16) were
imilarly tested. Stripped sera were used in certain ex-
eriments. Sixteen hours after transfection, the monolay-
rs were washed and treated with ethanol vehicle or the
elevant ligand (VDR, 10 nM 1,25-(OH)2D3; GR, 1 mM
dexamethasone; ER, 10 nM b-estradiol; RAR, 10 nM all-
rans-retinoic acid). GH secreted into the media was
uantitated 24 h following ligand addition using an im-
unoassay kit (Nichols Institute, San Juan Capistrano,
A). The results represent the means 6SD of duplicate
eterminations.Western Blot Assay. Cell monolayers were solubilized
n SDS sample buffer and resolved in 12% polyacryl-
lmide gels, and then separated proteins were trans-
erred onto PVDF membrane. Blocked membranes were
ncubated for 1 h with primary antibody (1:2500 dilution of
olyclonal anti-MC013L rabbit serum or 1:100 dilution of
at monoclonal antibody 947g against VDR) followed by
n additional 1-h incubation with the second antibody
MC013L, 1:50,000 dilution of polyclonal goat anti-rabbit,
nd VDR, 1:8000 dilution of polyclonal goat anti-rat
Kirkegaard and Perry Laboratories, MD)]. The blots were
eveloped with the ECL system (Amersham, IL).
Yeast Two-Hybrid Assays. All two-hybrid plasmid con-
tructs used pAS1 or pGBT9 (bait) and the pGAD.GH
prey) vectors (29). pAS1 contained a nuclear localiza-
ion sequence preceding the DNA-binding domain of
al41–147, which was fused in frame to the ligand-binding
domains of huVDR94–427, RAR143–391, muGR513–783, or huER263–
95 or p53. Also, the complete ORFs for snf4 and Ga were
cloned into pAS1 as specificity controls. The MC013L WT
and MC013L mutated genes were cloned as in frame
fusions with the nuclear-targeted activation domain of
Gal4786–881. Plasmids pGAD424.GRIP1/f1 and pGBT9–
muGR513–783 were constructed as described previously
(30, 31). The pGAD.GH WT and mutant MC013L plasmids
were co-transformed with pAS1 derivatives into yeast
strain SFY526 and incubated for 3 days at 30°C on
leucine- and tryptophan-deficient plates containing li-
gand. After 3 days at 30°C, triplicate colonies were
picked and cultured overnight in SC-selective liquid cul-
ture media containing ligand. Cells were assayed for
b-galactosidase activity as described (32).
GST Fusion Proteins and the in Vitro Protein Binding
Assay. The ligand-binding domains of huVDR116–427,
muGR513–783, and huER263–595 were inserted into the
GEX-KT expression vector (Pharmacia Biotech Inc., Pis-
ataway, NJ). The GST fusion proteins were expressed
nd purified by glutathione–agarose affinity chromatog-
aphy. 35S-labeled MC013L was generated using the
NT-coupled transcription–translation system (Promega,
adison, WI) and reacted with 5 mg of GST, GST–VDR,
ST–GR, or GST–ER previously bound (in the presence
r absence of appropriate ligand) to glutathione–agarose
s described (16). Eluted proteins were resolved by 10%
DS–PAGE and visualized by autoradiography, and band
ntensity was quantified by Phosphorimagery analysis.
Far Western Blot. The assay was carried out as de-
cribed previously (16). Briefly, GST fusion proteins were
ubjected to SDS–PAGE and electrophoretically trans-
erred to PVDF membranes followed by a denaturation
nd renaturation cycle. The renatured blots were incu-
ated overnight at 4°C in H buffer (20 mM HEPES, pH 7.7,
5 mM KCl, 0.1 mM EDTA, 2.5 mM MgCl2, 0.05% NP-40,
% nonfat dried milk, and 1 mM DTT) containing a 32P-abeled WT or L125/126A GST–MC013L probe (;500,000
cpm/ml), but no ligand. After three washes in H buffer,
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24 RAPID COMMUNICATIONthe protein blots were subjected to autoradiography for
;3 h at RT.
Immunofluorescence. pMT3A–MC013L was trans-
fected into slide cultures of COS-7 cells, and 48 h later
the cells were fixed with 4% paraformaldehyde in PBS at
4°C for 10 min. The cells were permeabilized at 220°C
with methanol containing 0.5 mg/ml DAPI for 6 min and
ashed twice with methanol alone. Cells were rehy-
rated in PBS and treated first with a 1:2500 dilution of a
abbit polyclonal antibody against bacterially expressed
is-tagged MC013L (pRSET C vector; Invitrogen, San
iego, CA), followed by goat anti-rabbit immunoglobulin
conjugated to fluorescein isothiocyanate (Organon
eknika, PA). Photographs were taken on Kodak T-Max
00 film using a Nikon epifluorescence microscope
quipped with a 603 Plan apo objective lens.
Immunocytochemistry on Formalin Fixed and Wax Em-
edded Molluscum Contagiosum Specimens. The tis-
ues were reacted for 30 min at ambient temperature
ith a 1:500 dilution of polyclonal rabbit antibody against
C013L. Bound antibody was detected with a 1:200
ilution of biotinylated goat anti-rabbit antibody in an
BC–horseradish peroxidase developing system using
,39-diaminobenzidine as the substrate and following the
ompany’s directions (Vector Laboratories, Inc., Burlin-
ame, CA). The tissue sections were counter-stained
ith hematoxylin, washed, coated in crystal mount, and
overslipped with permount.
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